## Clinical Context The patient has developed a nitrate-induced headache, a well-recognized and common adverse effect that occurs due to vasodilation of cerebral blood vessels. This is NOT a reason to discontinue therapy if symptom control is excellent. ## Mechanism of Nitrate Headache Nitrates cause vasodilation via activation of guanylate cyclase and increased cyclic GMP in vascular smooth muscle. Cerebral vasodilation triggers the headache. This effect is **dose-dependent** and **self-limiting**. ## Key Point: **Nitrate-induced headache develops tolerance (tachyphylaxis) within 1–2 weeks of continuous use.** Patients should be counseled to persist with therapy rather than discontinue. ## Management Strategy | Approach | Rationale | |----------|----------| | **Continue nitrate + reassure patient** | Tolerance develops; headache resolves spontaneously | | Offer paracetamol or ibuprofen for symptomatic relief | Safe adjunctive measure during tolerance phase | | Maintain once-daily dosing schedule | Allows 10–14 hour nitrate-free interval to prevent tolerance to antianginal effect | | **Do NOT reduce dose or switch class** | Symptom control is excellent; no clinical justification | ## High-Yield: **Tolerance to the *antianginal* effect of nitrates (not the headache) is prevented by a nitrate-free interval of ≥10–12 hours daily.** Once-daily long-acting nitrates inherently provide this interval. ## Clinical Pearl: Nitrate tolerance (loss of antianginal efficacy) is a separate phenomenon from headache tolerance. The once-daily isosorbide mononitrate regimen is specifically designed to prevent nitrate tolerance while allowing headache tolerance to develop. ## Warning: **Do NOT add a phosphodiesterase-5 inhibitor (sildenafil, tadalafil) to a patient on nitrates.** This combination causes severe, potentially life-threatening hypotension and is absolutely contraindicated.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.